Hypertonic Lactate After Cardiac Arrest
Recruiting
Phase 2
Interventional Study
Cardiac Arrest
Ischemia Reperfusion Injury
Anoxic Brain Injury
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 125 (estimated)
- Sponsor
- Erasme University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study is intended to test the hypothesis that sodium lactate infusion after resuscitation from a cardiac arrest will decrease the magnitude of brain damage, as measured by the serum biomarker concentration of NSE.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age \> 18 years old
* Sustained (\> 20 minutes) return of spontaneous circulation (ROSC)
* Comatose (GCS \< 9)
* Time to ROSC \> 15'
Exclusion Criteria:
* Protected categories (Pregnant women)
* Anticipated withdrawal of support within 24 hours
* Traumatic cause of cardiac a…
Contacts